NasdaqCM - Delayed Quote • USD
Viking Therapeutics, Inc. (VKTX)
At close: April 25 at 4:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 1,440,749 | 14 |
| Sales | 504,079 | 7 |
| Net Shares Purchased (Sold) | 936,670 | 21 |
| Total Insider Shares Held | 6.65M | -- |
| % Net Shares Purchased (Sold) | 16.40% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ZANTE GREGORY S Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 27, 2024 |
| LIAN BRIAN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 27, 2024 |
| MANCINI MARIANNA Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 27, 2024 |
| ZANTE GREGORY S Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| LIAN BRIAN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| MANCINI MARIANNA Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| LIAN BRIAN Chief Executive Officer | Sale at price 29.90 per share. | Direct | 1,345,500 | Feb 9, 2024 |
| LIAN BRIAN Chief Executive Officer | Sale at price 25.75 - 28.90 per share. | Direct | 7,230,784 | Feb 8, 2024 |
| LIAN BRIAN Chief Executive Officer | Conversion of Exercise of derivative security at price 1.23 - 4.65 per share. | Direct | 711,367 | Feb 8, 2024 |
| ROUAN SARAH KATHRYN Director | Sale at price 28.05 per share. | Direct | 701,250 | Feb 8, 2024 |
| ROUAN SARAH KATHRYN Director | Conversion of Exercise of derivative security at price 8.32 per share. | Direct | 208,000 | Feb 8, 2024 |
| LIAN BRIAN Chief Executive Officer | Sale at price 24.45 - 24.95 per share. | Direct | 2,100,750 | Jan 31, 2024 |
| LIAN BRIAN Chief Executive Officer | Conversion of Exercise of derivative security at price 1.23 per share. | Direct | 104,550 | Jan 31, 2024 |
| LIAN BRIAN Chief Executive Officer | Sale at price 23.95 per share. | Direct | 838,250 | Jan 30, 2024 |
| LIAN BRIAN Chief Executive Officer | Conversion of Exercise of derivative security at price 1.23 per share. | Direct | 43,050 | Jan 30, 2024 |
| ROUAN SARAH KATHRYN Director | Sale at price 23.05 per share. | Direct | 691,500 | Jan 19, 2024 |
| ROUAN SARAH KATHRYN Director | Conversion of Exercise of derivative security at price 8.32 per share. | Direct | 249,600 | Jan 19, 2024 |
| ZANTE GREGORY S Chief Financial Officer | Sale at price 17.90 per share. | Direct | 268,500 | Jan 4, 2024 |
| ZANTE GREGORY S Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2024 |
| LIAN BRIAN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2024 |
| MANCINI MARIANNA Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2024 |
| ROWLAND CHARLES A JR Director | Sale at price 25.00 per share. | Direct | 1,000,000 | May 16, 2023 |
| ROWLAND CHARLES A JR Director | Conversion of Exercise of derivative security at price 1.08 per share. | Direct | 43,200 | May 16, 2023 |
| MACARTNEY LAWSON Director | Sale at price 24.00 per share. | Direct | 384,000 | May 16, 2023 |
| MACARTNEY LAWSON Director | Conversion of Exercise of derivative security at price 1.19 per share. | Direct | 19,040 | May 16, 2023 |
| LIAN BRIAN Chief Executive Officer | Sale at price 22.45 per share. | Direct | 1,010,250 | May 1, 2023 |
| MACARTNEY LAWSON Director | Sale at price 22.00 per share. | Direct | 352,061 | Apr 24, 2023 |
| MACARTNEY LAWSON Director | Conversion of Exercise of derivative security at price 3.33 per share. | Direct | 53,280 | Apr 24, 2023 |
| LIAN BRIAN Chief Executive Officer | Sale at price 21.45 per share. | Direct | 750,750 | Apr 19, 2023 |
| ZANTE GREGORY S Chief Financial Officer | Sale at price 20.00 per share. | Direct | 150,000 | Apr 17, 2023 |
| ZANTE GREGORY S Chief Financial Officer | Conversion of Exercise of derivative security at price 13.07 per share. | Direct | 98,025 | Apr 17, 2023 |
| MACARTNEY LAWSON Director | Sale at price 20.00 per share. | Direct | 415,720 | Apr 17, 2023 |
| MACARTNEY LAWSON Director | Conversion of Exercise of derivative security at price 8.00 per share. | Direct | 166,288 | Apr 17, 2023 |
| LIAN BRIAN Chief Executive Officer | Sale at price 20.45 per share. | Direct | 3,169,766 | Apr 17, 2023 |
| LIAN BRIAN Chief Executive Officer | Conversion of Exercise of derivative security at price 2.15 per share. | Direct | 268,750 | Apr 17, 2023 |
| MANCINI MARIANNA Chief Operating Officer | Sale at price 20.00 per share. | Direct | 250,000 | Apr 17, 2023 |
| MANCINI MARIANNA Chief Operating Officer | Conversion of Exercise of derivative security at price 13.07 per share. | Direct | 163,375 | Apr 17, 2023 |
| LIAN BRIAN Chief Executive Officer | Sale at price 18.45 per share. | Direct | 1,463,749 | Apr 13, 2023 |
| LIAN BRIAN Chief Executive Officer | Conversion of Exercise of derivative security at price 1.88 per share. | Direct | 102,152 | Apr 13, 2023 |
| ZANTE GREGORY S Chief Financial Officer | Sale at price 18.00 per share. | Direct | 1,761,310 | Apr 12, 2023 |
| ZANTE GREGORY S Chief Financial Officer | Conversion of Exercise of derivative security at price 4.68 - 7.77 per share. | Direct | 544,804 | Apr 12, 2023 |
| ZANTE GREGORY S Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 3, 2023 |
| ZANTE GREGORY S Chief Financial Officer | Sale at price 17.00 - 18.00 per share. | Direct | 2,784,219 | Apr 3, 2023 |
| ZANTE GREGORY S Chief Financial Officer | Conversion of Exercise of derivative security at price 4.12 - 8.52 per share. | Direct | 923,661 | Apr 3, 2023 |
| LIAN BRIAN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 3, 2023 |
| LIAN BRIAN Chief Executive Officer | Sale at price 16.95 - 17.85 per share. | Direct | 4,211,292 | Apr 3, 2023 |
| LIAN BRIAN Chief Executive Officer | Conversion of Exercise of derivative security at price 1.23 - 9.49 per share. | Direct | 972,873 | Mar 31, 2023 |
| MANCINI MARIANNA Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 30, 2023 |
| MANCINI MARIANNA Chief Operating Officer | Conversion of Exercise of derivative security at price 6.47 - 8.52 per share. | Direct | 293,122 | Mar 30, 2023 |
| MANCINI MARIANNA Chief Operating Officer | Sale at price 15.00 - 16.00 per share. | Direct | 3,608,317 | Mar 29, 2023 |
Related Tickers
MDGL Madrigal Pharmaceuticals, Inc.
194.38
-5.02%
NVO Novo Nordisk A/S
125.79
-0.29%
ALT Altimmune, Inc.
7.20
+1.69%
VRTX Vertex Pharmaceuticals Incorporated
397.70
-0.76%
IOVA Iovance Biotherapeutics, Inc.
11.54
-1.45%
IBRX ImmunityBio, Inc.
5.11
+6.02%
RXRX Recursion Pharmaceuticals, Inc.
7.84
-1.26%
CRSP CRISPR Therapeutics AG
53.73
-3.45%
DAWN Day One Biopharmaceuticals, Inc.
13.21
-13.03%
JANX Janux Therapeutics, Inc.
47.10
-2.30%